Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Grace Therapeutics, Inc. | StockGist | StockGist

Companies
GRCE
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings GRCESCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Grace Therapeutics, Inc.

Filed Feb 13, 2026

Accepted Feb 12, 2026, 7:00 PM ET

CIK 0001444192

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Grace Therapeutics, Inc.

Person Type

IA

CUSIP: 00439U104

Amendment History

8 filings

SCHEDULE 13G
Original
May 15, 20250001104659-25-049554
SCHEDULE 13G/A
Amendment 1
Jan 29, 20250001493152-25-004067
SCHEDULE 13G/A
Amendment 2
May 8, 20250001641172-25-009166
SCHEDULE 13G/A
Amendment 3
May 15, 20250001104659-25-049671
SCHEDULE 13G/A
Amendment 4
Aug 14, 20250001104659-25-078718
SCHEDULE 13G/A
Amendment 5
Jan 28, 20260001493152-26-003982
SCHEDULE 13G/A
Amendment 6
Viewing
Feb 13, 20260001104659-26-015316
SCHEDULE 13G/A
Amendment 7
Latest
Feb 17, 20260001104659-26-016618

Recent Filings

Grace Therapeutics, Inc.1 months ago

Grace Therapeutics, Inc.1 months ago

Grace Therapeutics, Inc.1 months ago

Grace Therapeutics, Inc.2 months ago

Grace Therapeutics, Inc.2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice